GENENCOR INTERNATIONAL INC
10-Q, EX-27, 2000-09-11
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENENCOR INTERNATIONAL INC, 10-Q, EX-11, 2000-09-11
Next: FIRST FEDERAL BANCSHARES INC /DE, 424B3, 2000-09-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM GENENCOR
INTERNATIONAL, INC.'S QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED JUNE
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          52,203
<SECURITIES>                                     1,420
<RECEIVABLES>                                   49,344
<ALLOWANCES>                                     2,056
<INVENTORY>                                     50,220
<CURRENT-ASSETS>                               162,525
<PP&E>                                         373,410
<DEPRECIATION>                                 163,475
<TOTAL-ASSETS>                                 494,549
<CURRENT-LIABILITIES>                           61,339
<BONDS>                                        144,263
                          151,563
                                          0
<COMMON>                                           519
<OTHER-SE>                                     111,523
<TOTAL-LIABILITY-AND-EQUITY>                   494,549
<SALES>                                        150,266
<TOTAL-REVENUES>                               159,390
<CGS>                                           85,261
<TOTAL-COSTS>                                   85,261
<OTHER-EXPENSES>                                37,202
<LOSS-PROVISION>                                   328
<INTEREST-EXPENSE>                               5,270
<INCOME-PRETAX>                                 31,657
<INCOME-TAX>                                    10,426
<INCOME-CONTINUING>                             21,231
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    21,231
<EPS-BASIC>                                        .35
<EPS-DILUTED>                                      .33


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission